Synopsys Inc. (SNPS)
Synopsys, Inc. (SNPS) Is a Trending Stock: Facts to Know Before Betting on It
Recently, Zacks.com users have been paying close attention to Synopsys (SNPS). This makes it worthwhile to examine what the stock has in store.
Synopsys offers to sell two assets in bid for EU okay for $35 bln Ansys deal, sources say
Chip design software company Synopsys has offered to sell an Ansys unit on top of one of its own in a bid to win EU approval for its $35 billion acquisition of the chip design software company, three people with direct knowledge of the matter said.
Semiconductor Giant Synopsys Slides 14% — Time to Take Notice
Indisputably, one of the most important companies in the world of semiconductors is Synopsys NASDAQ: SNPS. The company has established an ironclad position as one of the key providers of semiconductor design software.
Synopsys offers remedies to address EU concerns over Ansys deal
Chip design software company Synopsys has offered remedies to address EU antitrust concerns about its $35 billion cash-and-stock acquisition of engineering software maker Ansys , according to a European Commission filing on Tuesday.
Synopsys: The Downside When Stocks Are Priced To The Point Of Perfection
Synopsys' recent stock price drop is justified due to lower-than-expected FY25 guidance, impacting the 5-year outlook and reducing upside potential. Synopsys remains a dominant player in the EDA and IP markets, but a high multiple and shareholder dilution pose risks to future returns. I have downgraded Synopsys to Hold due to weaker guidance, economic uncertainties, and the potential for better entry points.
Wall Street Bulls Look Optimistic About Synopsys (SNPS): Should You Buy?
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
S&P 500 Gains and Losses Today: Synopsys Sinks as China Restrictions Hurt Outlook
Major U.S. equities indexes hovered near record levels in Thursday trading before closing lower ahead of Friday morning's employment report.
Synopsys Q4: Anticipating Revenue Deceleration In FY 2025; Remain 'Sell'
Synopsys, Inc.'s stock remains overvalued despite 11% revenue growth and weak guidance, reiterating a “Sell” rating with a fair value of $394 per share. The acquisition of Ansys for $35 billion is strategically favorable, promising synergies and integration benefits in the semiconductor design and simulation markets. Weak end-market demands and a pessimistic outlook for China's semiconductor industry are expected to hinder Synopsys's growth in FY25.
Synopsys Stock Is the S&P 500's Worst Performer Today
Synopsys (SNPS) shares tumbled after the chip design software maker posted a disappointing forecast for its coming fiscal year late Wednesday.
Synopsys Stock Dives On Outlook. Another AI Red Flag?
Synopsys stock plunged after the chip design company guided low on revenue, though some analysts remain upbeat. The post Synopsys Stock Dives On Outlook.
SNPS CFO on Role in A.I. Race, Cut Guidance & Ansys Acquisition
Shelagh Glaser, CFO of Synopsys (SNPS), discusses the direction she aims to take the company after investors traded the stock down. She explains part of the reason Synopsys cut guidance was due to the setup of the calendar year, reiterating that revenue growth shows promise in its outlook.
Synopsys Q4 Earnings Beat Estimates, Stock Dips 7% on Weak Guidance
SNPS' Q4 results reflect an impressive rise in top and bottom lines, driven by strong growth across multiple business segments.
